Johnson MR - Search Results

1

Importance of dihydropyrimidine dehydrogenase (DPD) deficiency in patients exhibiting toxicity following treatment with 5-fluorouracil.

Johnson MR, Diasio RB. Johnson MR, et al. Adv Enzyme Regul. 2001;41:151-7. doi: 10.1016/s0065-2571(00)00011-x. Adv Enzyme Regul. 2001. PMID: 11384742 No abstract available.

2

A comparative analysis of translated dihydropyrimidine dehydrogenase cDNA; conservation of functional domains and relevance to genetic polymorphisms.

Mattison LK, Johnson MR, Diasio RB. Mattison LK, et al. Among authors: johnson mr. Pharmacogenetics. 2002 Mar;12(2):133-44. doi: 10.1097/00008571-200203000-00007. Pharmacogenetics. 2002. PMID: 11875367

3

Profound dihydropyrimidine dehydrogenase deficiency resulting from a novel compound heterozygote genotype.

Johnson MR, Wang K, Diasio RB. Johnson MR, et al. Clin Cancer Res. 2002 Mar;8(3):768-74. Clin Cancer Res. 2002. PMID: 11895907

4

A high-throughput denaturing high-performance liquid chromatography method for the identification of variant alleles associated with dihydropyrimidine dehydrogenase deficiency.

Ezzeldin H, Okamoto Y, Johnson MR, Diasio RB. Ezzeldin H, et al. Among authors: johnson mr. Anal Biochem. 2002 Jul 1;306(1):63-73. doi: 10.1006/abio.2002.5666. Anal Biochem. 2002. PMID: 12069415

5

Denaturing high performance liquid chromatography analysis of the DPYD gene in patients with lethal 5-fluorouracil toxicity.

Ezzeldin H, Johnson MR, Okamoto Y, Diasio R. Ezzeldin H, et al. Among authors: johnson mr. Clin Cancer Res. 2003 Aug 1;9(8):3021-8. Clin Cancer Res. 2003. PMID: 12912951

6

Rapid identification of dihydropyrimidine dehydrogenase deficiency by using a novel 2-13C-uracil breath test.

Mattison LK, Ezzeldin H, Carpenter M, Modak A, Johnson MR, Diasio RB. Mattison LK, et al. Among authors: johnson mr. Clin Cancer Res. 2004 Apr 15;10(8):2652-8. doi: 10.1158/1078-0432.ccr-03-0374. Clin Cancer Res. 2004. PMID: 15102667

7

Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.

Salonga D, Danenberg KD, Johnson M, Metzger R, Groshen S, Tsao-Wei DD, Lenz HJ, Leichman CG, Leichman L, Diasio RB, Danenberg PV. Salonga D, et al. Clin Cancer Res. 2000 Apr;6(4):1322-7. Clin Cancer Res. 2000. PMID: 10778957 Clinical Trial.

8

cDNA cloning of bovine liver dihydropyrimidine dehydrogenase.

Albin N, Johnson MR, Diasio RB. Albin N, et al. Among authors: johnson mr. DNA Seq. 1996;6(4):243-50. doi: 10.3109/10425179609008450. DNA Seq. 1996. PMID: 8912928

9

Structural organization of the human dihydropyrimidine dehydrogenase gene.

Johnson MR, Wang K, Tillmanns S, Albin N, Diasio RB. Johnson MR, et al. Cancer Res. 1997 May 1;57(9):1660-3. Cancer Res. 1997. PMID: 9135003

10

Semi-automated radioassay for determination of dihydropyrimidine dehydrogenase (DPD) activity. Screening cancer patients for DPD deficiency, a condition associated with 5-fluorouracil toxicity.

Johnson MR, Yan J, Shao L, Albin N, Diasio RB. Johnson MR, et al. J Chromatogr B Biomed Sci Appl. 1997 Aug 29;696(2):183-91. doi: 10.1016/s0378-4347(97)00253-3. J Chromatogr B Biomed Sci Appl. 1997. PMID: 9323539

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

996 results

Search Page

Filters